Archive for the ‘RX MD Inc’ Category

Rx MD Inc

July 8th, 2011 | Posted in 2011, RX MD Inc

Rx MD Inc., San Diego:  A privately-held therapeutics development company, announced a Collaboration Agreement with GlycoRegImmune Inc.  (GRI) also San Diego-based, to develop new treatments for inflammatory autoimmune and neurodegenerative conditions based on GRI’s novel natural killer (NK) T cell targeted technologies. Under the Agreement RXMed Inc. will use its global drug development expertise, including its […]